Wagner, J., Yuen, L., Littlejohn, M., Sozzi, V., Jackson, K., Martin, R., . . . Revill, P. A. (2023). Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B. Alimentary pharmacology & therapeutics, 57(5), 509-523. https://doi.org/10.1111/apt.17299
Chicago Style (17th ed.) CitationWagner, Josef, et al. "Hepatitis B Virus Haplotype Number at Baseline Is a Predictive Marker of Functional Cure During Antiviral Therapy for Patients with Genotypes A and D HBeAg‐positive Chronic Hepatitis B." Alimentary Pharmacology & Therapeutics 57, no. 5 (2023): 509-523. https://doi.org/10.1111/apt.17299.
MLA (9th ed.) CitationWagner, Josef, et al. "Hepatitis B Virus Haplotype Number at Baseline Is a Predictive Marker of Functional Cure During Antiviral Therapy for Patients with Genotypes A and D HBeAg‐positive Chronic Hepatitis B." Alimentary Pharmacology & Therapeutics, vol. 57, no. 5, 2023, pp. 509-523, https://doi.org/10.1111/apt.17299.